Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second-trimester termination after 1-day versus 2-day mifepristone-misoprostol interval
ISRCTN09944151Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mifepristone and misoprostol in abortion (2 arms), sponsored by Helsinki University Hospital. Primary endpoints: Time to termination of pregnancy and Need for surgical curettage. Started Jun 2008; status: completed.
02
Drugs
mifepristonemisoprostol
03
Conditions
abortion
Beyond the preview
Go deeper on ISRCTN09944151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN09944151.